Lucentis, Avastin Equally Good in Wet AMD (CME/CE)
(MedPage Today) -- After 2 years of treatment, the endothelial growth factor inhibitors ranibizumab and bevacizumab are proving similar in ability to improve visual acuity in patients with wet age-related macular degeneration, researchers found.